Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fisher HealthCare, part of Thermo Fisher Scientific, has entered into an agreement to distribute Response's infectious disease point of care (POC) test panel, which currently includes the RAMP Flu A + B test and the RAMP RSV test, in the US.
Subscribe to our email newsletter
Response’s Flu A + B and RSV tests run on the RAMP 200 Reader diagnostic platform, which features multi-port capability to run up to 12 tests per hour on one module and up to 36 tests per hour, using three modules.
The Reader detects positive or negative results within 15 minutes that are directly correlated with the presence or absence of the Flu A and B nucleoprotein antigens or RSV F-protein antigen.
The fluorescence-reading Reader also eliminates user interpretation errors, which can lead to both false negative or false positive results as well as stores test results, which give lab technicians more flexibility in time and test management.